These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 2768842)

  • 1. Growth inhibition of human nasopharyngeal carcinoma in athymic mice by anti-epidermal growth factor receptor monoclonal antibodies.
    Guan E; Zhou TC; Wang JH; Huang PG; Tang WP; Zhao ML; Chen Y; Sun YX
    Int J Cell Cloning; 1989 Jul; 7(4):242-56. PubMed ID: 2768842
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of monoclonal antibody anti-EGF receptor on human nasopharyngeal carcinoma cell and other tumor cells.
    Guan EN; Zhou TC; Wang JH; Chen Y; Sun YX; Huang PG; Tang WP; Zhao ML
    Sci China B; 1990 Nov; 33(11):1334-40. PubMed ID: 2095159
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Growth inhibition of human tumor cells in athymic mice by anti-epidermal growth factor receptor monoclonal antibodies.
    Masui H; Kawamoto T; Sato JD; Wolf B; Sato G; Mendelsohn J
    Cancer Res; 1984 Mar; 44(3):1002-7. PubMed ID: 6318979
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cytotoxicity against human tumor cells mediated by the conjugate of anti-epidermal growth factor receptor monoclonal antibody to recombinant ricin A chain.
    Masui H; Kamrath H; Apell G; Houston LL; Mendelsohn J
    Cancer Res; 1989 Jul; 49(13):3482-8. PubMed ID: 2786451
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Blockade of epidermal growth factor receptor function by bivalent and monovalent fragments of 225 anti-epidermal growth factor receptor monoclonal antibodies.
    Fan Z; Masui H; Altas I; Mendelsohn J
    Cancer Res; 1993 Sep; 53(18):4322-8. PubMed ID: 8364927
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Suppression of an epidermal growth factor receptor-hyperproducing tumor by an immunotoxin conjugate of gelonin and a monoclonal anti-epidermal growth factor receptor antibody.
    Hirota N; Ueda M; Ozawa S; Abe O; Shimizu N
    Cancer Res; 1989 Dec; 49(24 Pt 1):7106-9. PubMed ID: 2555059
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mechanism of antitumor activity in mice for anti-epidermal growth factor receptor monoclonal antibodies with different isotypes.
    Masui H; Moroyama T; Mendelsohn J
    Cancer Res; 1986 Nov; 46(11):5592-8. PubMed ID: 3756906
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibitory effect of anti-epidermal growth factor receptor antibody on a human gastric cancer.
    Teramoto T; Onda M; Tokunaga A; Asano G
    Cancer; 1996 Apr; 77(8 Suppl):1639-45. PubMed ID: 8608556
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Biological effects in vitro of monoclonal antibodies to human epidermal growth factor receptors.
    Sato JD; Kawamoto T; Le AD; Mendelsohn J; Polikoff J; Sato GH
    Mol Biol Med; 1983 Dec; 1(5):511-29. PubMed ID: 6094961
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antitumor effect of anti-epidermal growth factor receptor monoclonal antibodies plus cis-diamminedichloroplatinum on well established A431 cell xenografts.
    Fan Z; Baselga J; Masui H; Mendelsohn J
    Cancer Res; 1993 Oct; 53(19):4637-42. PubMed ID: 8402640
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of epidermal growth factor on transferrin receptor phosphorylation and surface expression in malignant epithelial cells.
    Castagnola J; MacLeod C; Sunada H; Mendelsohn J; Taetle R
    J Cell Physiol; 1987 Sep; 132(3):492-500. PubMed ID: 3498729
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Acquired resistance to the antitumor effect of epidermal growth factor receptor-blocking antibodies in vivo: a role for altered tumor angiogenesis.
    Viloria-Petit A; Crombet T; Jothy S; Hicklin D; Bohlen P; Schlaeppi JM; Rak J; Kerbel RS
    Cancer Res; 2001 Jul; 61(13):5090-101. PubMed ID: 11431346
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A monoclonal antibody to the human epidermal growth factor receptor.
    Waterfield MD; Mayes EL; Stroobant P; Bennet PL; Young S; Goodfellow PN; Banting GS; Ozanne B
    J Cell Biochem; 1982; 20(2):149-61. PubMed ID: 6188757
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Eradication of established tumors by a fully human monoclonal antibody to the epidermal growth factor receptor without concomitant chemotherapy.
    Yang XD; Jia XC; Corvalan JR; Wang P; Davis CG; Jakobovits A
    Cancer Res; 1999 Mar; 59(6):1236-43. PubMed ID: 10096554
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reciprocal changes in p27(Kip1) and p21(Cip1) in growth inhibition mediated by blockade or overstimulation of epidermal growth factor receptors.
    Fan Z; Shang BY; Lu Y; Chou JL; Mendelsohn J
    Clin Cancer Res; 1997 Nov; 3(11):1943-8. PubMed ID: 9815583
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Epidermal growth factor receptor monoclonal antibodies inhibit the growth of lung cancer cell lines.
    Lee M; Draoui M; Zia F; Gazdar A; Oie H; Bepler G; Bellot F; Tarr C; Kris R; Moody TW
    J Natl Cancer Inst Monogr; 1992; (13):117-23. PubMed ID: 1327029
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of chemomigration of a human prostatic carcinoma cell (TSU-pr1) line by inhibition of epidermal growth factor receptor function.
    Zolfaghari A; Djakiew D
    Prostate; 1996 Apr; 28(4):232-8. PubMed ID: 8602399
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anti-tumor activity of monoclonal antibody CIBCNSH3 generated to the human EGF receptor.
    Udayachander M; Dean CJ; Meenakshi AN; Sivakumar N; Babu PB; Sivakumar J
    Hum Antibodies; 1997; 8(2):60-4. PubMed ID: 9289389
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tyrosine kinase inhibitors. 14. Structure-activity relationships for methylamino-substituted derivatives of 4-[(3-bromophenyl)amino]-6-(methylamino)-pyrido[3,4-d]pyrimidine (PD 158780), a potent and specific inhibitor of the tyrosine kinase activity of receptors for the EGF family of growth factors.
    Rewcastle GW; Murray DK; Elliott WL; Fry DW; Howard CT; Nelson JM; Roberts BJ; Vincent PW; Showalter HD; Winters RT; Denny WA
    J Med Chem; 1998 Feb; 41(5):742-51. PubMed ID: 9513602
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anti-epidermal growth factor receptor monoclonal antibodies may inhibit A431 tumor cell proliferation by blocking an autocrine pathway.
    Mendelsohn J; Masui H; Goldenberg A
    Trans Assoc Am Physicians; 1987; 100():173-8. PubMed ID: 3502661
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.